DnaJ heat shock protein family (Hsp40) member A1 pseudogene 3Genealiases: []
Q-omics provides the consensus-scored DNAJA1P3 profile across patient tissues and cancer cell-line models. DNAJA1P3 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in STAD. Among the 18 cancer types available for tumor–normal comparison, DNAJA1P3 is differentially expressed in 12, with the highest sampling consensus in HNSC. Additionally, DNAJA1P3 RNA expression shows 15,286 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight STAD, HNSC, and UVM as cancer lineages where DNAJA1P3 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for DNAJA1P3 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes DNAJA1P3 survival associations across molecular data types. DNAJA1P3 RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible DNAJA1P3 RNA expression–survival associations across cancer types. High DNAJA1P3 expression shows unfavorable associations in STAD, LUSC, MESO and ESCA, but favorable associations in COAD and THCA. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify STAD as the clearest survival context for DNAJA1P3 RNA expression.
This table summarizes DNAJA1P3 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for DNAJA1P3. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. DNAJA1P3 shows lower tumor expression in KICH and higher tumor expression in HNSC, COAD, UCEC, BLCA and LUAD. The HNSC box plot shows higher DNAJA1P3 RNA expression in tumor versus normal tissue (log2 FC = +0.195, t-test p < 0.001).
This table shows molecular features associated with DNAJA1P3 in patient tissues and cancer cell lines. In patient samples, DNAJA1P3 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
